Details for New Drug Application (NDA): 016110
✉ Email this page to a colleague
NDA 016110 describes PROLIXIN ENANTHATE, which is a drug marketed by Apothecon and is included in one NDA. Additional details are available on the PROLIXIN ENANTHATE profile page.
The generic ingredient in PROLIXIN ENANTHATE is fluphenazine enanthate. There are nineteen drug master file entries for this compound. Additional details are available on the fluphenazine enanthate profile page.
The generic ingredient in PROLIXIN ENANTHATE is fluphenazine enanthate. There are nineteen drug master file entries for this compound. Additional details are available on the fluphenazine enanthate profile page.
Summary for 016110
| Tradename: | PROLIXIN ENANTHATE |
| Applicant: | Apothecon |
| Ingredient: | fluphenazine enanthate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 25MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
